Forskellen mellem behandlingsregimerne var generelt ikke påvirket af forekomst/ fravær af cirrose; derfor er behandlingsanbefalingerne for genotype 1, 2 og 3 uafhængige af denne baselinekarakteristika.
The difference between treatment regimens was in general not influenced by presence/ absence of cirrhosis; therefore treatment recommendations for genotype 1, 2 or 3 are independent of this baseline characteristic.